tru Independence’s Bristol-Myers Squibb BMY Stock Holding History

tru Independence’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,009	Closed	-$67K	–	208
2021 Q2	$67K	Buy	+1,009	New	+$65.8K	0.02%	169
2021 Q1	–	Sell	-34	Closed	-$2	–	339
2020 Q4	$2	Sell	34 -66	-66%	-$4.06K	﹤0.01%	630
2020 Q3	$6K	Sell	100 -1,027,472	-100%	-$61.8M	﹤0.01%	292
2020 Q2	$19	Buy	+1,027,572	New	+$61.5M	﹤0.01%	506
2020 Q1	–	Sell	-1,081,698	Closed	-$49.3M	–	735
2019 Q4	$49.3M	Buy	+1,081,698	New	+$61.9M	7.09%	1

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

tru Independence's BMY Position: Q3 2021 in Review

tru Independence sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 1,009 shares — an estimated $67K sold.

tru Independence first reported a position in BMY in Q4 2019 and held it in 5 quarters. The position peaked at $49.3M in Q4 2019. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

tru Independence reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
tru Independence sold 1,009 Bristol-Myers Squibb shares in Q3 2021, an estimated $67K.
tru Independence first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 5 quarters.
tru Independence's Bristol-Myers Squibb position peaked at $49.3M in Q4 2019.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on tru Independence's 13F filing for Q3 2021, filed 12 Nov 2021.